Adjuvants shape the quality and durability of vaccine responses through early innate immune programs. Using multi-omics profiling of human vaccinees, we identify conserved early transcriptional and cellular signatures that predict subsequent adaptive responses across distinct adjuvant platforms, providing a framework for rational adjuvant selection.
Related products
| Catalog No. | Product Name | Description | Target |
|---|---|---|---|
| HF998207 | Anti-Human CD4 Antibody (5A8) | CD4, T-cell surface antigen T4/Leu-3, T-cell surface glycoprotein CD4 |
+86-27-65523339
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский